| __timestamp | Arrowhead Pharmaceuticals, Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 2854000000 |
| Thursday, January 1, 2015 | 57410147 | 3014000000 |
| Friday, January 1, 2016 | 41454452 | 5098000000 |
| Sunday, January 1, 2017 | 31690298 | 3734000000 |
| Monday, January 1, 2018 | 52968505 | 5018000000 |
| Tuesday, January 1, 2019 | 81048686 | 9106000000 |
| Wednesday, January 1, 2020 | 128874979 | 5039000000 |
| Friday, January 1, 2021 | 206342000 | 5363000000 |
| Saturday, January 1, 2022 | 297307000 | 4977000000 |
| Sunday, January 1, 2023 | 353188000 | 6923000000 |
| Monday, January 1, 2024 | 505870000 | 5907000000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. Gilead Sciences, Inc. and Arrowhead Pharmaceuticals, Inc. are two prominent players in this arena, each with a distinct approach to research and development (R&D) investment. Over the past decade, Gilead has consistently outpaced Arrowhead, investing nearly 32 times more in R&D on average. In 2019, Gilead's R&D expenses peaked, reaching a staggering 9.1 billion dollars, while Arrowhead's highest investment was approximately 506 million dollars in 2024. Despite the disparity, Arrowhead has shown a remarkable growth trajectory, increasing its R&D spending by over 2,000% from 2014 to 2024. This trend highlights Arrowhead's commitment to innovation, even as Gilead remains a dominant force. As the biotech landscape evolves, these investments will shape the future of healthcare breakthroughs.
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Genmab A/S
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Bio-Techne Corporation
Research and Development Investment: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Gilead Sciences, Inc. vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Gilead Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Xencor, Inc.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.